Apotheek Luyten SRL
2.4 FTEApotheek Luyten reported total assets of €1.76m at the end of the 2025 financial year (annual accounts filed with the NBB on 19 Aug 2026), with 2.4 full-time equivalents.
The score of Apotheek Luyten shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +45 % Total assets +121 % Headcount (avg FTE) +33 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek Luyten's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 19 Aug 2026
- Year ended 31 Dec 2024filed on 18 Aug 2025
- Year ended 31 Dec 2023filed on 19 Jul 2024
- Year ended 31 Dec 2022filed on 04 Jul 2023
- Year ended 31 Dec 2021filed on 12 Jul 2022
Apotheek Luyten's financial analysis
- Solvency35.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek Luyten
Apotheek Luyten's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0450.363.476
- VAT number
- BE0450363476
- Peppol
- Registered · 0208:0450363476 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 17 Jun 1993
- Registered office
- 2560 Nijlen
- Size
- Micro · 2.4 FTE
- Latest accounts
- 2025 · filed on 19 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek Luyten (SRL) has been based in Nijlen since 1993, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 86,059 € and equity of 614,938 €; its revenue is not published. With 2.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 35.0%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Apotheek Luyten
Companies in the same business, of comparable size and area, outside its group.
- Inge Thoelen Retail sale of pharmaceutical products Landen · balance sheet €1.74m
- Selvais Retail sale of pharmaceutical products Bastogne · balance sheet €1.75m
- Hampharma Retail sale of pharmaceutical products Tessenderlo-Ham · balance sheet €1.75m
- Mooy Pharma Retail sale of pharmaceutical products Veurne · balance sheet €1.74m
- Apelec Retail sale of pharmaceutical products Zemst · balance sheet €1.74m
- Pharmacie Gosselin-Obourg Retail sale of pharmaceutical products Mons · balance sheet €1.77m
- D4-Pharma Retail sale of pharmaceutical products Etterbeek · balance sheet €1.77m
- Den Baksteen Retail sale of pharmaceutical products Asse · balance sheet €1.73m
Frequently asked questions about Apotheek Luyten
What is the revenue of Apotheek Luyten?
Apotheek Luyten files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheek Luyten?
In Belgium, the VAT number is the company number prefixed with BE: BE0450363476 for Apotheek Luyten, if the company is VAT-registered. Its company number (CBE) is 0450.363.476.
Where is the registered office of Apotheek Luyten?
According to the CBE register, the registered office of Apotheek Luyten is in 2560 Nijlen.
What is the equity of Apotheek Luyten?
At the close of the 2025 financial year, the equity of Apotheek Luyten amounts to 614,938 €, a solvency of 35.0% of total assets.
How many people work at Apotheek Luyten?
2.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Apotheek Luyten?
The register lists 2 active mandates at Apotheek Luyten. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek Luyten
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →